The company has significantly advanced this course of a new treatment for cardiac amyloidosis, leveraging Attruby. Early patient information suggests significant outcomes for patients suffering with this serious https://attrcm134841.onesmablog.com/bridgebio-improves-attr-cm-treatment-with-the-therapy-83633156